Sunshine Guojian Pharmaceutical Shanghai Co Ltd

688336 • SHG

¥41.65¥0.00 (0%)

Estimate

P/E

12.1

EPS

3.43

Beta

0.344

Growth

Revenue, YoY

31.3%

Net income, YoY

121.14%

FCF, YoY

-16.53%

Forecast

P/E (FWD)

50.2

EPS (FWD)

0.83

Dividends

Dividend yield

2.16%

Annual payout

¥0.90

Next ex. div date

December 18, 26

Payout

0.65%

Dividend growth streak

2 y

Div.rating

About the company

Ticker

688336

ISIN

CNE1000062X2

Country

Other

Sector (GICS)

Healthcare

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include Enbrel, a recombinant human type II tumor necrosis factor receptor-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation; and Enbrel, an anti-IL-17A humanized monoclonal antibody ambroxol injection for the treatment of moderate to severe plaque psoriasis. The company was founded in 2002 and is based in Shanghai, China.

Frequently asked questions

What sector does Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) operate in?

Sunshine Guojian Pharmaceutical Shanghai Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) current stock price?

As of the latest data, Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock price is CN¥41.65, with a previous close of CN¥41.65.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) current market capitalization?

Sunshine Guojian Pharmaceutical Shanghai Co Ltd market cap is approximately 37.33 billion.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) Earnings Per Share (EPS)?

The trailing EPS is CN¥3.43, and the forward EPS is CN¥0.83.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) Price-to-Earnings (P/E) ratio?

Sunshine Guojian Pharmaceutical Shanghai Co Ltd current P/E ratio is 12.14, with a forward P/E of 50.18.

Does Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) pay dividends?

Yes. Sunshine Guojian Pharmaceutical Shanghai Co Ltd pays semiannual dividends with an annualized yield of 2.16% and an estimated annual payout of CN¥0.90 per share.

When is the next ex-dividend date for Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336)?

The next ex-dividend date is scheduled for December 18, 2026.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336) beta (volatility) score?

Sunshine Guojian Pharmaceutical Shanghai Co Ltd has a beta of 0.344, indicating lower volatility than the overall market.